Kenneth N. Olivier

Five-Year Outcomes among U.S. Bronchiectasis and NTM Research Registry Patients

Germline mutations in a G protein identify signaling cross-talk in T cells

Preclinical murine models for the testing of antimicrobials against Mycobacterium abscessus pulmonary infections: Current practices and recommendations

Airway inflammation accelerates pulmonary exacerbations in cystic fibrosis

Long-term Safety and Tolerability of Omadacycline for the Treatment of <i>Mycobacterium abscessus</i> Infections

Evolution of <i>Mycobacterium abscessus</i> in the human lung: Cumulative mutations and genomic rearrangement of porin genes in patient isolates

Consensus management recommendations for less common non-tuberculous mycobacterial pulmonary diseases

Clinical exome sequencing of 1000 families with complex immune phenotypes: Toward comprehensive genomic evaluations

Immunogenetics associated with severe coccidioidomycosis

SARS-CoV-2 Reverse Genetics Reveals a Variable Infection Gradient in the Respiratory Tract

Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS/ERS/ESCMID/IDSA clinical practice guideline

Treatment of Nontuberculous Mycobacterial Pulmonary Disease: An Official ATS/ERS/ESCMID/IDSA Clinical Practice Guideline

Treatment of Nontuberculous Mycobacterial Pulmonary Disease: An Official ATS/ERS/ESCMID/IDSA Clinical Practice Guideline

Airway Clearance Techniques in Bronchiectasis

Pseudomonas aeruginosa associated with severity of non-cystic fibrosis bronchiectasis measured by the modified bronchiectasis severity score (BSI) and the FACED: The US bronchiectasis and NTM Research Registry (BRR) study

Nutrition and Markers of Disease Severity in Patients With Bronchiectasis

Lymphocyte-driven regional immunopathology in pneumonitis caused by impaired central immune tolerance

The Clinical Features of Bronchiectasis Associated with Alpha-1 Antitrypsin Deficiency, Common Variable Immunodeficiency and Primary Ciliary Dyskinesia--Results from the U.S. Bronchiectasis Research Registry

Prospective multicenter randomized patient recruitment and sample collection to enable future measurements of sputum biomarkers of inflammation in an observational study of cystic fibrosis

Treatment outcome definitions in nontuberculous mycobacterial pulmonary disease: an NTM-NET consensus statement

Advancing Translational Science for Pulmonary Nontuberculous Mycobacterial Infections. A Road Map for Research

The Prevalence and Significance of <i>Staphylococcus aureus</i> in Patients with Non–Cystic Fibrosis Bronchiectasis

Pharmacotherapy for Non-Cystic Fibrosis Bronchiectasis

MPEG1/perforin-2 mutations in human pulmonary nontuberculous mycobacterial infections

Adult Patients With Bronchiectasis

Randomized Trial of Liposomal Amikacin for Inhalation in Nontuberculous Mycobacterial Lung Disease

Clinical Features and Associated Likelihood of Primary Ciliary Dyskinesia in Children and Adolescents

Patient-Centered Research Priorities for Pulmonary Nontuberculous Mycobacteria (NTM) Infection. An NTM Research Consortium Workshop Report

Clinical Features and Associated Likelihood of Primary Ciliary Dyskinesia in Children and Adolescents

The association between sterilizing activity and drug distribution into tuberculosis lesions